Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells

Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis

(2008) Daniela Matei et al.   CANCER

Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma

(2008) Fariba Navid et al.   CANCER

Imatinib resistance in CML

(2008) Gisella Volpe et al.   CANCER LETTERS

Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study

(2008) Giuseppe Di Lorenzo et al.   EUROPEAN UROLOGY

Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation

(2008) R. K. Kancha et al.   HAEMATOLOGICA

Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line

(2008) Francesco Fabbri et al.   Journal of Translational Medicine

Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy

(2008) Ju-Huei Chien et al.   LEUKEMIA RESEARCH

PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases

(2008) Artur Gontarewicz et al.   LEUKEMIA RESEARCH

Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: Role of COX-2 and MDR-1

(2008) Kalle M. Arunasree et al.   LEUKEMIA RESEARCH

Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels

(2008) Donna L. Forrest et al.   LEUKEMIA RESEARCH

Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: A multicenter phase II study

(2008) I. Boukovinas et al.   LUNG CANCER

Selected Combination Therapy with Sorafenib: A Review of Clinical Data and Perspectives in Advanced Solid Tumors

(2008) L. Dal Lago et al.   ONCOLOGIST

Dynamics and Potential Impact of the Immune Response to Chronic Myelogenous Leukemia

(2008) Peter S. Kim et al.   PLoS Computational Biology